Page last updated: 2024-09-03

garenoxacin and Bacteremia

garenoxacin has been researched along with Bacteremia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kurokawa, M; Nakamura, F; Nannya, Y; Shinohara, A; Taoka, K; Uni, M; Yamazaki, S; Yoshimi, A	1
Akahoshi, Y; Ashizawa, M; Ishihara, Y; Kako, S; Kanda, J; Kanda, Y; Kawamura, K; Kikuchi, M; Kimura, SI; Machishima, T; Nakano, H; Nakasone, H; Nishida, J; Sakamoto, K; Sato, M; Terasako-Saito, K; Ugai, T; Wada, H; Yamasaki, R; Yamazaki, R	1
Goldstein, EJ	1

Trials

1 trial(s) available for garenoxacin and Bacteremia

Article	Year
Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia. International journal of hematology, 2017, Volume: 105, Issue:6 Topics: Acute Disease; Adolescent; Adult; Aged; Allografts; Anti-Bacterial Agents; Bacteremia; Female; Fluoroquinolones; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Levofloxacin; Male; Middle Aged; Neutropenia; Retrospective Studies	2017

Article

Year

Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia.

International journal of hematology, 2017, Volume: 105, Issue:6

Topics: Acute Disease; Adolescent; Adult; Aged; Allografts; Anti-Bacterial Agents; Bacteremia; Female; Fluoroquinolones; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Levofloxacin; Male; Middle Aged; Neutropenia; Retrospective Studies

2017

Other Studies

2 other study(ies) available for garenoxacin and Bacteremia

Article	Year
Comparison of garenoxacin with levofloxacin as antimicrobial prophylaxis in acute myeloid leukemia. Japanese journal of clinical oncology, 2015, Volume: 45, Issue:8 Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacterial Infections; Febrile Neutropenia; Female; Fluoroquinolones; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Primary Prevention; Retrospective Studies; Sample Size	2015
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Sep-01, Volume: 35, Issue:Suppl 1 Topics: Abdominal Abscess; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Ertapenem; Fluoroquinolones; Gemifloxacin; Humans; Indoles; Lactams; Moxifloxacin; Naphthyridines; Quinolines; Quinolones	2002

Article

Year

Comparison of garenoxacin with levofloxacin as antimicrobial prophylaxis in acute myeloid leukemia.

Japanese journal of clinical oncology, 2015, Volume: 45, Issue:8

Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacterial Infections; Febrile Neutropenia; Female; Fluoroquinolones; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Primary Prevention; Retrospective Studies; Sample Size

2015

Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Sep-01, Volume: 35, Issue:Suppl 1

Topics: Abdominal Abscess; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Ertapenem; Fluoroquinolones; Gemifloxacin; Humans; Indoles; Lactams; Moxifloxacin; Naphthyridines; Quinolines; Quinolones

2002